Protective effects of antidepressants against chronic fatigue syndrome-induced behavioral changes and biochemical alterations.
Study Design
- Study Type
- Other
- Population
- None
- Duration
- 1.0 weeks
- Intervention
- Protective effects of antidepressants against chronic fatigue syndrome-induced behavioral changes and biochemical alterations. None
- Comparator
- None
- Primary Outcome
- Protective effects of antidepressants against chronic fatigue syndrome-induced b
- Effect Direction
- Positive
- Risk of Bias
- Moderate
Abstract
Chronic fatigue syndrome (CFS) is characterized by profound fatigue, which substantially interferes with daily activities. The aim of this study was to explore the protective effects of antidepressants in an animal model of CFS in mice. Male albino mice were forced to swim individually for a period of 6-min session each for 7 days. Imipramine (10 and 20 mg/kg), desipramine (10 and 20 mg/kg) and citalopram (5 and 10 mg/kg) were administered 30 min before forced swimming test on each day. Various behavior tests (immobility time, locomotor activity, anxiety-like behavior by plus maze and mirror chamber) followed by biochemical parameters (lipid peroxidation, reduced glutathione, catalase and nitrite level) were assessed in chronic stressed mice. Chronic forced swimming for 7 days significantly caused increase in immobility period, impairment in locomotor activity, anxiety-like behavior, and oxidative stress (raised lipid peroxidation, nitrite activity and reduced glutathione and catalase activity) as compared with naïve mice (P < 0.05). Seven days of pretreatment with imipramine (10 and 20 mg/kg), desipramine (10 and 20 mg/kg), and citalopram (5 and 10 mg/kg) significantly reduced immobility time, improved locomotor activity and anti-anxiety effect (in both plus maze and mirror chamber test), and attenuated oxidative stress in chronic stressed mice as compared with control (chronic fatigues) (P < 0.05). These results suggested that these drugs have protective effect and could be used in the management of chronic fatigue like conditions.
TL;DR
The results suggested that these drugs have protective effect and could be used in the management of chronic fatigue like conditions.
Used In Evidence Reviews
Similar Papers
BMC medicine · 2015
The many roads to mitochondrial dysfunction in neuroimmune and neuropsychiatric disorders.
Journal of internal medicine · 2005
Chronic fatigue syndrome: assessment of increased oxidative stress and altered muscle excitability in response to incremental exercise.
Molecular neurobiology · 2014
The glutathione system: a new drug target in neuroimmune disorders.
Free radical biology & medicine · 2000
Specific oxidative alterations in vastus lateralis muscle of patients with the diagnosis of chronic fatigue syndrome.
Journal of clinical and diagnostic research : JCDR · 2013
Role of reactive oxygen species and antioxidants in atopic dermatitis.
NMR in biomedicine · 2012